Understanding Immunotherapy for Brain Cancer
When someone is diagnosed with brain tumors, there are various ways doctors try to fight the disease. One of the newer and more exciting approaches is immunotherapy for brain cancer.
This article will focus solely on this type of treatment, explaining what it is, how it works, different cancer immunotherapies being explored for brain tumors, and some of the potential side effects, all in simple language for everyone to understand.
What is Immunotherapy for Brain Cancer?
Our bodies have a natural defense system called the immune system, which is designed to fight off infections and diseases, including cancer. However, cancer cells can sometimes evade the immune system and grow unchecked.
Immunotherapy for brain is a type of treatment that helps your own immune system recognize and attack cancer cells more effectively. It’s like giving your body’s defense forces the tools and training they need to fight the brain tumors.
Unlike traditional chemotherapy drugs or radiation therapy, which directly target cancer cells (and sometimes healthy cells), immunotherapy works by boosting the body’s natural immune response against cancer.
This approach has shown promise in treating various types of cancer, and researchers are actively exploring its effectiveness of immunotherapy for brain tumors.
How Does Immunotherapy Work Against Brain Tumors?
Immunotherapy works in several different ways to help the immune system kill cancer cells. Some of the main strategies include:
- Checkpoint Inhibitors: Our immune system has “checkpoint” proteins that act like brakes, preventing immune cells called T cells from attacking healthy cells. Cancer cells can sometimes hijack these checkpoints to avoid being attacked. Checkpoint inhibitor drugs block these checkpoint proteins, releasing the brakes and allowing the T cells to recognize and attack cancer cells. Examples include drugs that target PD-1, PD-L1, and CTLA-4.
- T-Cell Transfer Therapy (including CAR T-cell therapy): This approach involves taking immune cells called T cells from the patient’s blood, modifying them in the lab to make them better at finding and attacking cancer cells, and then infusing them back into the patient. CAR T cell therapy is a specific type where T cells are engineered to have chimeric antigen receptors (CARs) on their surface. These CARs are designed to recognize specific proteins on the surface of cancer cells, allowing the 1 modified T cells to bind to and destroy them. While car t cell therapy has shown great success in blood cancers, its application in solid tumors like brain tumors is still under investigation.
- Cancer Vaccines: Similar to vaccines that protect against infections, cancer vaccines aim to teach the immune system to recognize and attack cancer cells. These vaccines might contain dead or weakened cancer cells, parts of cancer cells, or other substances that can trigger an immune response against the cancer. While still largely in the cancer research stage for brain tumors, they hold potential for future treatment strategies.
- Oncolytic Viruses: These are viruses that have been modified in the lab to selectively infect and kill cancer cells without harming healthy cells. As the virus replicates inside the cancer cells, it eventually causes them to burst. Additionally, the viral infection can trigger a broader immune response against the remaining cancer cells. Oncolytic virus therapy is being explored in clinical trials for certain brain tumors.
- Monoclonal Antibodies: These are laboratory-created proteins that are designed to bind to specific targets on cancer cells. Some monoclonal antibody drugs work by directly attacking the cancer cells, while others help the immune system to recognize and destroy them. For example, some monoclonal antibodies can block growth signals on cancer cells or make them more visible to immune cells.
Types of Brain Tumors Being Treated with Immunotherapy
Immunotherapy for brain is being investigated for various types of brain tumors, including:
- Glioblastoma: This is an aggressive and challenging-to-treat type of brain cancer where immunotherapy approaches like checkpoint inhibitors and oncolytic viruses are being actively studied.
- Medulloblastoma: This is a type of brain tumor that occurs mainly in children. Immunotherapy is being explored as a potential treatment, particularly for recurrent cases.
- Other Brain Metastases: When cancer from other parts of the body spreads to the brain, immunotherapy that has been effective against the primary cancer might also have a role in treating these secondary brain tumors.
Potential Side Effects of Immunotherapy
Like any cancer treatment, immunotherapy for brain can have side effects. These side effects occur because the immune system, now more active, can sometimes attack healthy cells called T cells in the body as well. However, the side effects of immunotherapy are often different and sometimes less severe than those associated with traditional chemotherapy.
Common side effects of immunotherapy can include:
- Flu-like symptoms: Fever, chills, fatigue, muscle aches.
- Skin reactions: Rash, itching.
- Gastrointestinal issues: Diarrhea, nausea.
- Inflammation in other organs: In rare cases, immunotherapy can cause inflammation in organs like the lungs, liver, or intestines.
The severity of these side effects can vary depending on the type of immunotherapy, the dose, and the individual patient. Doctors closely monitor patients receiving immunotherapy and have ways to manage these side effects if they occur. It’s crucial for patients to report any new or worsening symptoms to their medical team promptly.
The Role of Cancer Research and Clinical Trials
Cancer research is continuously working to improve the effectiveness of immunotherapy for brain tumors. Clinical trials are a vital part of this process. They allow researchers to test new immunotherapy approaches and combinations of treatments to see if they are safe and effective.
Technological advancements like single cell rna sequencing are helping scientists better understand the complex interactions between brain tumors and the immune system at a very detailed level. This knowledge is crucial for developing more targeted and effective immunotherapies.
Participating in a clinical trial can be an option for some patients with brain tumors, offering access to cutting-edge treatments that are not yet widely available. Patients should discuss the possibility of joining a clinical trial with their doctor.
The Future of Immunotherapy for Brain Cancer
While immunotherapy has shown significant promise in treating some cancers, its application in brain tumors is still evolving. The unique environment of the brain and the challenges of getting immune cells to effectively infiltrate brain tissue present specific hurdles.
However, ongoing cancer research and the development of novel cancer immunotherapies are constantly pushing the boundaries. Combinations of immunotherapy with other treatments, such as surgery, radiation, and targeted therapy, are also being explored to improve outcomes for patients with brain tumors.
Immunotherapy for brain cancer represents an exciting and rapidly advancing field in the fight against these challenging diseases. By harnessing the power of the body’s own immune system to attack cancer cells, it offers a different approach compared to traditional treatments.
While still facing challenges, ongoing cancer research and clinical trials are paving the way for more effective and potentially less toxic therapies for brain tumors.
Understanding the principles of immunotherapy and the different cancer immunotherapies being explored provides hope for the future treatment of brain cancer.
Support the Darren Daulton Foundation:
Learn how you can make a difference by visiting our Donate page.
If you’d like to contribute your time and skills, please visit our Volunteer page.
For those in need of financial assistance during their cancer journey, you can find more information on our Financial Assistance page.
Disclaimer: The information provided here by the Darren Daulton Brain Cancer Foundation is for educational purposes and general guidance only. It is not a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider.
